As of Oct 24
| -0.002 / -2.33%|
The 4 analysts offering 12-month price forecasts for Mast Therapeutics Inc have a median target of 2.75, with a high estimate of 5.00 and a low estimate of 2.00. The median estimate represents a +3,173.81% increase from the last price of 0.08.
The current consensus among 4 polled investment analysts is to Hold stock in Mast Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.